safinamide has been researched along with Nerve Pain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishida, T; Kobayashi, Y; Koebis, M; Kogo, Y; Maeda, T | 1 |
| Dustrude, ET; Khanna, R; Kohn, H; Park, KD; Ripsch, MS; Wang, Y; White, FA; Yang, XF | 1 |
2 other study(ies) available for safinamide and Nerve Pain
| Article | Year |
|---|---|
Analgesic effect of safinamide mesylate in a rat model of neuropathic pain.
Topics: Alanine; Analgesics; Animals; Antiparkinson Agents; Benzylamines; Male; Mesylates; Monoamine Oxidase Inhibitors; Neuralgia; Parkinson Disease; Quality of Life; Rats | 2023 |
Chimeric agents derived from the functionalized amino acid, lacosamide, and the α-aminoamide, safinamide: evaluation of their inhibitory actions on voltage-gated sodium channels, and antiseizure and antinociception activities and comparison with lacosamid
Topics: Acetamides; Alanine; Analgesics; Animals; Anticonvulsants; Benzylamines; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Female; Formaldehyde; Lacosamide; Male; Membrane Potentials; Mice; Neuralgia; Neurons; Patch-Clamp Techniques; Rats, Sprague-Dawley; Seizures; Tibial Nerve; Voltage-Gated Sodium Channel Blockers; Voltage-Gated Sodium Channels | 2015 |